|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 14.67 USD | -1.61% |
|
-7.33% | +95.60% |
| Market Cap | 810M 698M 655M 598M 1.13B 77.46B 1.13B 7.77B 3.03B 39.1B 3.04B 2.98B 130B | P/E 2026 * |
-3.55x | P/E 2027 * | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 615M 530M 497M 454M 855M 58.81B 858M 5.9B 2.3B 29.68B 2.31B 2.26B 98.43B | EV / Sales 2026 * |
48.2x | EV / Sales 2027 * | 22.5x |
| Free-Float |
97.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : 4D Molecular Therapeutics, Inc.
| 1 day | -1.61% | ||
| 1 week | -7.33% | ||
| Current month | +44.11% | ||
| 1 month | +48.93% | ||
| 3 months | +63.55% | ||
| 6 months | +51.86% | ||
| Current year | +95.60% |
| 1 week | 14.2 |  | 16.34 |
| 1 month | 9.66 | | 16.93 |
| Current year | 6.96 | | 16.93 |
| 1 year | 5.97 | | 16.93 |
| 3 years | 2.24 | | 36.25 |
| 5 years | 2.24 | | 36.25 |
| 10 years | 2.24 | | 55.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Theresa Janke
COO | Chief Operating Officer | 51 | 2018-03-31 |
David Kirn
CEO | Chief Executive Officer | 64 | 2013-09-11 |
Kristian Humer
DFI | Director of Finance/CFO | 51 | 2025-11-16 |
| Director | Title | Age | Since |
|---|---|---|---|
David Kirn
CHM | Chairman | 64 | 2013-09-11 |
Charles Theuer
BRD | Director/Board Member | 62 | 2015-11-30 |
Jacob Chacko
BRD | Director/Board Member | 47 | 2019-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/19/26 | Fiscal year | Founder | 169,076 | 0.3234% | ||
| 8/17/26 | Fiscal year | Compliance Officer | 4,905 | 0.0094% | ||
| 8/4/26 | Sell | Founder | -26,842 | 0.0513% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.61% | -7.33% | +137.38% | -12.89% | 810M | |
| -0.78% | -1.42% | +2.49% | +22.78% | 50.47B | |
| -6.00% | -0.75% | +442.41% | +544.39% | 44.56B | |
| -0.24% | +0.74% | +38.69% | +18.02% | 43.08B | |
| -1.55% | -2.07% | +23.08% | +81.47% | 41.7B | |
| -0.31% | -0.83% | +16.15% | +51.42% | 33.21B | |
| -1.79% | -3.24% | +27.00% | +129.56% | 16.77B | |
| -0.58% | -2.12% | - | - | 16.28B | |
| -0.88% | -0.66% | +11.60% | +27.75% | 14.58B | |
| -1.66% | -1.25% | +78.59% | +46.66% | 13.92B | |
| Average | -1.54% | -1.68% | +86.38% | +101.02% | 27.54B | |
| Weighted average by Cap. | -1.70% | -1.08% | +95.84% | +133.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12.77M 11M 10.31M 9.42M 17.74M 1.22B 17.79M 122M 47.74M 616M 47.93M 46.89M 2.04B | 21.2M 18.27M 17.13M 15.64M 29.45M 2.03B 29.55M 203M 79.29M 1.02B 79.6M 77.86M 3.39B |
| Net income | -293M -252M -237M -216M -407M -28B -408M -2.81B -1.1B -14.13B -1.1B -1.08B -46.87B | -315M -271M -255M -232M -438M -30.11B -439M -3.02B -1.18B -15.2B -1.18B -1.16B -50.4B |
| Net Debt | -195M -168M -158M -144M -271M -18.65B -272M -1.87B -730M -9.42B -733M -717M -31.22B | -334M -288M -270M -246M -464M -31.93B -466M -3.2B -1.25B -16.12B -1.25B -1.23B -53.44B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | US$14.67 | -1.61% | 1,101,307 |
| 26-08-27 | US$14.91 | -4.18% | 717,739 |
| 26-08-26 | US$15.56 | -1.02% | 717,884 |
| 26-08-25 | US$15.72 | +2.14% | 919,118 |
| 26-08-24 | US$15.39 | -2.78% | 1,474,743 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FDMT Stock
Select your edition
All financial news and data tailored to specific country editions
